Peptide Safety: What the Evidence Shows About Risks and Quality

Peptides sold online as “research chemicals” are not approved for human use, and what is in the vial is often unknown. The best-documented test, from 2024, found vials sold as semaglutide that were mostly not semaglutide. This page covers what testing, FDA and drug labels show. It does not give doses or injection steps.

What Did Testing Of Online Peptides Find?

A 2024 study in the Journal of Medical Internet Research made test purchases of semaglutide from illegal online pharmacies. Researchers reviewed 1,080 search links, found 59 illegal pharmacy sites, and ordered from 6 of them. Three vials arrived. The Ozempic pens that were ordered never arrived.

• Measured purity was 7.7% to 14.37%, against 99% claimed.
• Semaglutide content was 28.56% to 38.69% above the label amount.
• Endotoxin was found in every sample, at 2.16 to 8.95 EU/mg.
• The vials had no viable microorganisms at the time of testing.
• Visual inspection failed 59% to 63% of criteria, so all three were judged probably substandard or falsified.

That is three vials of one drug. It does not show that every peptide is contaminated. It does show that a label can be wrong by a wide margin.

A 2026 review of unregulated peptide use describes consumer use of products whose identity, purity, potency, sterility and safety are uncertain, and names weak monitoring of side effects as part of the problem.

What Does FDA Say About Unapproved Peptides?

On FDA’s compounding page, FDA lists bulk substances that may pose safety risks when compounded. Examples:

• Kisspeptin-10 and emideltide (DSIP): FDA says compounded drugs containing them “may pose risk for immunogenicity for certain routes of administration.”
• Ibutamoren (MK-677): FDA cites a trial that was stopped early for a potential safety signal of congestive heart failure.
• Emideltide: FDA says it lacks enough information to know whether the drug would cause harm if given to humans.
• BPC-157: listed as a withdrawn nomination, with the note that FDA has identified “no, or only limited, safety-related information.”

FDA has also said that a “research use only” label does not make a product legal to sell for human use.

What Do The Human Studies Show For BPC-157 And TB-500?

Very little. A 2026 systematic review found three human studies of BPC-157 with 30 participants in total: a knee-pain chart review, a bladder study and an IV safety pilot in 2 people. The studies were small and rated poor quality, and the certainty of the evidence was very low. The authors concluded BPC-157 should not be used clinically outside approved, high-quality trials.

A 2026 orthopaedic review found no controlled human orthopaedic efficacy evidence for BPC-157, thymosin beta-4 or TB-500, and said routine clinical use cannot currently be recommended. It also notes TB-500 is a distinct seven-amino-acid fragment, not proven equivalent to full-length thymosin beta-4.

What Do Labels Warn About For Approved GLP-1 Drugs?

Approved peptide drugs come with labels you can read. The Wegovy label lists two contraindications:

• A personal or family history of medullary thyroid carcinoma (MTC), or multiple endocrine neoplasia type 2 (MEN 2).
• A prior serious hypersensitivity reaction to semaglutide or to any of its ingredients.

Uncontrolled diabetes is not a listed contraindication. GLP-1 drugs are used to treat diabetes.

The label also warns that Wegovy lowers blood glucose and raises the risk of hypoglycemia when used with insulin or insulin secretagogues, and suggests considering a lower dose of the insulin. It notes that delayed stomach emptying may affect absorption of oral medicines, and advises more monitoring for drugs with a narrow therapeutic index.

Are Tesamorelin And Sermorelin Approved?

Tesamorelin is FDA-approved, as Egrifta, for reducing excess abdominal fat in HIV-infected adults with lipodystrophy. Sermorelin was once FDA-approved and is no longer sold. Neither is approved as an anti-aging or general wellness product.

How Do You Read A Peptide Lab Report?

• Match the lot number on the report to the lot number on your vial.
• Check that an independent lab ran the test, and look the lab up yourself.
• HPLC gives purity. Mass spectrometry confirms identity. Neither measures endotoxin or sterility.
• Endotoxin and sterility are separate tests. Sterility testing follows USP <71>, and endotoxin limits depend on the dose and the person’s weight.
• A single “99% purity” line tells you nothing about what the other 1% is.

See our peptide vendors ranked by lab-report evidence and our fake peptide vendors list.

When Should You Get Urgent Help?

Call emergency services if you have trouble breathing, swelling of the face, lips or tongue, a widespread rash, or fainting after any injection. Tell your clinician about any peptide you use. They need to know to check for drug interactions.

What Is The Safest Choice?

Approved medicines through a prescriber, with a label you can read and a pharmacy that checks the product. If you are weighing anything else, talk to a clinician first. This page is for information only and is not medical advice.

References

• Ashraf AR, Mackey TK, Vida RG, et al. Multifactor quality and safety analysis of semaglutide products sold by online sellers without a prescription. J Med Internet Res. 2024;26:e65440. PMID 39509151.
• FDA. Certain bulk drug substances for use in compounding that may present significant safety risks (Category 2 and nominated-but-withdrawn lists).
• Wegovy (semaglutide) prescribing information, DailyMed. Section 4 (contraindications) and section 7 (drug interactions).
• Human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safety. Acta Orthop Belg. 2026;92(3). PMID 42885452.
• Investigational peptides in orthopaedic practice: evidence, safety, and patient counseling for BPC-157, thymosin beta-4, and TB-500. J Am Acad Orthop Surg. 2026. PMID 42937313.
• Unregulated peptide use in the age of biohacking: digital promotion, gray-market access, and emerging public health risks. Cureus. 2026;18(6):e110657. PMID 42437212.